Population
Patients with chronic renal disease and hypertension
Design
Review
Authors
Loading...
May support sympathetic inhibition trials in CKD hypertension; leaves open confirmation of renal and CV benefits in RCTs.
Highlights the role of sympathetic overactivity in driving hypertension, renal failure progression, and cardiac arrhythmias in patients with chronic renal disease.
Orth et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: